Adenoid basal cell carcinoma: An underrecognized cervical malignancy

IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Gynecologic Oncology Reports Pub Date : 2025-02-01 DOI:10.1016/j.gore.2024.101667
Arielle Katcher , Juliana Schilsky , Alisha Daroch , Tahyna Hernandez , Andrew Menzin , Lisa Dos Santos , Jill Whyte , Marina Frimer
{"title":"Adenoid basal cell carcinoma: An underrecognized cervical malignancy","authors":"Arielle Katcher ,&nbsp;Juliana Schilsky ,&nbsp;Alisha Daroch ,&nbsp;Tahyna Hernandez ,&nbsp;Andrew Menzin ,&nbsp;Lisa Dos Santos ,&nbsp;Jill Whyte ,&nbsp;Marina Frimer","doi":"10.1016/j.gore.2024.101667","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Adenoid basal cell carcinoma is a rare cervical malignancy which is indolent in nature but resembles more commonly occurring aggressive malignancies.</div></div><div><h3>Cases</h3><div>Here we describe three cases of cervical adenoid basal cell carcinoma. All patients had a history of cervical dysplasia with high-risk HPV. The first and second patient were treated with hysterectomy, and the third patient opted for surveillance after cold knife conization. All patients have no evidence of disease to date.</div></div><div><h3>Conclusion</h3><div>Cervical adenoid basal cell carcinoma is a rare malignancy that requires careful diagnostic attention due to its histologic similarities to more aggressive malignancies and the risk of misclassification. Advances in diagnostic criteria including immunohistochemistry (IHC) classification are key to distinguishing this unique pathological entity. Definitive treatment depends on accurate diagnosis. Optimal treatment involves surgical management with hysterectomy and lymph node assessment. Excisional biopsy with thorough pathologic evaluation for invasive carcinoma can be considered in patients who desire future fertility.</div></div>","PeriodicalId":12873,"journal":{"name":"Gynecologic Oncology Reports","volume":"57 ","pages":"Article 101667"},"PeriodicalIF":1.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732580/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic Oncology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352578924002467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Adenoid basal cell carcinoma is a rare cervical malignancy which is indolent in nature but resembles more commonly occurring aggressive malignancies.

Cases

Here we describe three cases of cervical adenoid basal cell carcinoma. All patients had a history of cervical dysplasia with high-risk HPV. The first and second patient were treated with hysterectomy, and the third patient opted for surveillance after cold knife conization. All patients have no evidence of disease to date.

Conclusion

Cervical adenoid basal cell carcinoma is a rare malignancy that requires careful diagnostic attention due to its histologic similarities to more aggressive malignancies and the risk of misclassification. Advances in diagnostic criteria including immunohistochemistry (IHC) classification are key to distinguishing this unique pathological entity. Definitive treatment depends on accurate diagnosis. Optimal treatment involves surgical management with hysterectomy and lymph node assessment. Excisional biopsy with thorough pathologic evaluation for invasive carcinoma can be considered in patients who desire future fertility.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腺样基底细胞癌:一种未被充分认识的宫颈恶性肿瘤。
腺样基底细胞癌是一种罕见的宫颈恶性肿瘤,本质上是惰性的,但类似于更常见的侵袭性恶性肿瘤。病例:我们在此报告三例宫颈腺样基底细胞癌。所有患者均有宫颈发育不良伴高危HPV病史。第1、2例患者行子宫切除术,第3例患者冷刀切腹后继续观察。到目前为止,所有患者均无发病证据。结论:宫颈腺样基底细胞癌是一种罕见的恶性肿瘤,由于其在组织学上与其他侵袭性恶性肿瘤相似,且有误诊的危险,需要仔细诊断。包括免疫组织化学(IHC)分类在内的诊断标准的进步是区分这种独特病理实体的关键。最终的治疗取决于准确的诊断。最佳治疗包括手术治疗,子宫切除术和淋巴结评估。对于希望将来生育的患者,可以考虑对浸润性癌进行切除活检并进行彻底的病理评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gynecologic Oncology Reports
Gynecologic Oncology Reports OBSTETRICS & GYNECOLOGY-
CiteScore
2.00
自引率
0.00%
发文量
183
审稿时长
41 days
期刊介绍: Gynecologic Oncology Reports is an online-only, open access journal devoted to the rapid publication of narrative review articles, survey articles, case reports, case series, letters to the editor regarding previously published manuscripts and other short communications in the field of gynecologic oncology. The journal will consider papers that concern tumors of the female reproductive tract, with originality, quality, and clarity the chief criteria of acceptance.
期刊最新文献
Views on cervical cancer screening among female caregivers at the Uganda cancer Institute “Developing a manual clinical trials screening process in a diverse southern gynecologic oncology practice” A novel MXI1-NUTM2B fusion detected in an undifferentiated ovarian cancer Provider perspectives on caring for patients with limited English proficiency-a national survey of the Society of Gynecologic Oncology Cervicitis decidualis mimicking cervical cancer in pregnancy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1